AbbVie looks beyond Humira with $63 billion deal for Botox-maker Allergan

June 25, 2019 by  
Filed under News

Drugmaker AbbVie Inc said on Tuesday it would buy Botox-maker Allergan Plc for about $63 billion, grabbing control of the biggest name in medical aesthetics to help reduce its reliance on blockbuster arthritis treatment Humira.

Source: Reuters Business News

Comments are closed.